|
No. |
Topic |
Summary |
Pages |
9103
| PAT - An FDA Update | - | 38 |
9104
| Quality by Design and Bioequivalence / Bioavailability Assessment | - | 41 |
9105
| PAT from an European Perspective | - | 58 |
9106
| Cost Benefits by PAT? | - | 39 |
9107
| Current Research and Resources for Understanding Drying of Pharmaceutical Materials | - | 48 |
9108
| Current Research and Resources for Understanding Blending of Pharmaceutical Materials | - | 47 |
9109
| The Science and Engineering of Tablet Coating | - | 40 |
9110
| Risk Analysis as the Basis for Implementing a PAT Strategy | - | 33 |
9111
| General Considerations of Sampling in a PAT Environment | - | 27 |
9112
| Utilysing Near-Infra-Red Microscopy and Complimentary Tools for Mechanistic Understanding of Pharmaceutical Manufacturing | - | 60 |
9113
| Data Management Challenges in a PAT Environment | 2 | 32 |
9114
| Statistical Techniques for PAT | - | 45 |
9115
| Beyond Process Analysis - Lessons Larned from a Holistic Approach to PAT | - | 53 |
9116
| A Regulatory Perspective of a PAT Driven Future | - | 27 |
9117
| Integrating PAT Equipment with Process Automation and Control Systems | 1 | 29 |
9118
| Principles and Practices of Process Design in a PAT Environment | - | 33 |
9119
| Design Space: A Pragmatic Perspective
| 25 | - |
9120
| PAT in API Manufacturing | - | 18 |
9121
| PAT - Training Needs and Resources | - | 46 |
